Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model
Neuromyelitis optica (NMO) is an autoimmune inflammatory demyelinating disease that mainly affects the spinal cord and optic nerve, causing blindness and paralysis in some individuals. Moreover, NMO may cause secondary complement-dependent cytotoxicity (CDC), leading to oligodendrocyte and neuronal...
Saved in:
Main Authors: | Yuanyuan Zhang, Kewei Tian, Hong Jiang, Beibei Wang, Shu Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/4187347 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis
by: Massa Zantah, et al.
Published: (2016-01-01) -
Neuromyelitis optica spectrum disorder: epidemiology, pathogenesis, diagnosis, treatment, and prognosis
by: J. Čemerkaitė, et al.
Published: (2021-03-01) -
Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
by: Jean-Baptiste Chanson, et al.
Published: (2013-01-01) -
The Big Yawning: Pathological Yawning as a Symptom of Neuromyelitis Optica Spectrum Disorders
by: Veronika Spahlinger, et al.
Published: (2019-01-01) -
Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
by: Ryohei Yamamura, et al.
Published: (2025-02-01)